Graciela Arhancet

Dr. Graciela Arhancet is Founder and a member of the Board of Directors of nanoSUR. She was Director of Innovation at Novus International, in St. Louis, MO (2010 – 2017) where she managed strategic technologies and new product innovation. Before joining Novus, Dr. Arhancet held various leadership positions in Drug Discovery and Early Development at Pfizer St. Louis Laboratories and its legacy companies for more than 11 years where she discovered and advanced two candidates into clinical trials for diabetic nephropathy and pain.

Dr. Arhancet earned a Doctorate degree in Organic Synthesis from Virginia Polytechnic Institute and a Bachelor’s degree in Chemical Engineering from Universidad de la Republica , Uruguay. She is the author and holder of more than fifty publications and patents.